FIELD: medicine.
SUBSTANCE: present group of inventions refers to endocrinology, and concerns preventing hypoglycaemia during type 2 of diabetes mellitus. That is ensured by administration of desPro36Ekzendin-4(1-39)-Lys6-NH2 (AVE0010) preparation or its pharmaceutically acceptable salt in combination with sulphonylurea preparation.
EFFECT: such complex administration provides effective prevention of hypoglycemia.
18 cl, 10 dwg, 33 tbl, 1 ex
